Open AccessClinical experience of using double bronchodilation therapy in patients with COPD
Author(s) -
I. V. Demko,
M. G. Mamayeva,
N. V. Gordeyeva,
I A Solovyeva,
А. Yu. Kraposhina
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-15-7-10
Subject(s) - medicine , copd , bronchodilation , spirometry , quality of life (healthcare) , pulmonary disease , intensive care medicine , physical therapy , lung function , clinical practice , disease , airway , bronchodilator , asthma , surgery , lung , nursing
Chronic obstructive pulmonary disease is today one of the socially significant diseases, and its treatment remains a major medical problem. Currently, the main goals of treating patients with COPD are: eliminating symptoms and improving the quality of life, preventing exacerbations and reducing future risks, slowing the progression of the disease and reducing mortality. The article presents a clinical case from the practice of a patient with COPD who received tiotropium bromidi as monotherapy. The patient had significant impaired airway patency during spirometry, a decrease in exercise tolerance. The patient was assigned a new representative of combination preparations with a 24-hour action – Anoro Ellipta® (Vilanterol + Umeklidiniy) 22/55 mcg, with a new drug delivery vehicle. After 6 months of therapy with Anoro Ellipt®, the patient has increased exercise tolerance, improved pulmonary function, as well as quality of life.